How to manage when-required medicines in a care home

Start with the person's need, not the next medicine round

A resident tells a care worker they are in pain two hours after the morning medicines round. Their chart includes a when-required medicine. The task is to assess and respond to the person's current need under the prescribed instructions. Waiting until the evening round merely because that is when staff usually open the trolley may leave the person distressed. Giving a dose without checking the last administration, reason and interval may create a different risk.

The phrase “when required,” often shortened to PRN, means that administration depends on defined circumstances rather than a fixed routine. CQC's PRN guidance says care-home staff should not limit PRN medicines to medicine rounds or MAR times. NICE SC1 says a care-home process should cover the reason to give the medicine, amount, expected effect, minimum interval and when to contact the prescriber. The medicine should be offered when needed, not simply at a convenient round.

Check the resident's care plan, prescription and label. What condition or symptom is the medicine for? What dose is authorised? Is there a variable range, and what tells staff which amount to choose? What is the minimum interval and maximum total in a defined period? When was the last dose actually taken? Are there other medicines that contain the same active ingredient or affect the decision? If the directions are unclear or inconsistent, seek prescriber or pharmacist clarification before administering. Care workers should not create their own dose algorithm.

Ask the resident about their symptoms and preferences. Their experience matters, including whether a previous dose helped or caused an unwanted effect. Record the assessment in the care system appropriate to the service. A worker's role is to observe, communicate and follow the authorised plan within competence. A PRN prescription does not mean any staff member can use the medicine to manage any distress they see.

Make the care plan specific enough for two different shifts

A useful PRN plan lets a trained worker on a night shift reach the same safe decision as a colleague on a day shift. It identifies the condition being treated, the signs or words that suggest the medicine may be needed, the prescribed dose and how a variable dose is chosen. It states the minimum interval, maximum permitted amount, route, expected effect and what to monitor. It also explains when the medicine should not be given and when professional advice is needed. These details must come from the prescriber and care planning process, not from an online template.

CQC guidance calls for a person-centred plan with the condition, dose instructions, daily maximum and minimum interval. NICE SC1 recommendation 1.14.2 adds the expected effect, when to check confusion with the prescriber and the instruction to offer the medicine when needed. A label that says “as directed” without accessible directions is not enough for a worker to choose a dose safely. NICE asks prescribers to provide clear instructions for variable-dose and PRN medicines.

Explain how the resident communicates need. Some residents ask directly. Others use a pain scale, a communication board or familiar words. For a person who cannot easily describe symptoms, an agreed assessment method and known baseline may help. Do not assume that agitation always means pain or that quietness means comfort. The care plan should show what staff have observed, how the resident's wishes were sought and when a clinician should reassess the cause.

Keep the plan current. A PRN medicine prescribed after an acute episode may no longer be needed months later. A resident's condition, ability to communicate, regular medicines or response can change. Put a review date and responsible professional in the plan. A medicine left on the list indefinitely without a meaningful indication can become routine by habit. Conversely, a useful medicine may be inaccessible if nobody has written practical instructions for staff.

Check the last dose and cumulative amount before giving another

The time of the last dose is a key safety fact. Check the MAR and any separate administration record, including doses given by visiting professionals or during a hospital visit. If the resident has returned from another care setting, NICE says transfer information should include the last dose time of PRN medicines. Ask for missing information rather than assuming that no entry means no dose. An incomplete handover can make a minimum interval impossible to verify.

For a variable dose, staff need a written basis for the amount selected. A choice between one and two tablets should not be left to whichever worker is on duty. Check the prescription, care plan, symptom assessment and any previous effect. If the instructions do not explain how to choose, ask the prescriber. Do not give the larger amount simply because the person is distressed or because a smaller amount did not help last week. Nor should staff always choose the smaller amount if the prescribed plan calls for a different response in defined circumstances.

Check the maximum daily amount according to the exact prescription and relevant professional advice. This may involve doses administered outside the home or a regular medicine with the same ingredient. The term “daily” can be interpreted differently, so the prescribed directions and pharmacist clarification matter. A generic page cannot set a universal interval or maximum. Keep the calculation visible in the clinical record where the service's process requires it.

If the previous dose had little effect, the response may be clinical reassessment rather than another automatic dose. The PRN plan should say what staff expect, when to check and when to seek advice. If symptoms are new, severe or changing, follow the resident's escalation plan. A medicine intended for one familiar symptom should not be used to mask a new problem without assessment.

Involve the resident in the decision

Explain what the medicine is for and ask whether the resident wants it, as far as they can participate. A PRN medicine should not be given simply because it is available. Respect a capacitated refusal and document it. If capacity is in doubt for the specific decision, follow the service's Mental Capacity Act process. An existing PRN prescription does not override consent. A covert or restrictive approach requires a separate lawful decision process and pharmaceutical advice.

Ask whether a non-medicine measure is wanted or already part of the plan. For pain or anxiety, the agreed care plan may include positioning, a quiet environment, reassurance or another intervention. These should not be used to deny a prescribed medicine when the person needs it. They may help staff understand and respond to the underlying need. The plan should be realistic for the resident and shift, not a list of generic alternatives that nobody can deliver.

Be especially careful with PRN medicines used for distress, agitation or sleep. CQC warns that medicines for distress and agitation should be prescribed for as short a time as possible and reviewed. The reason and effect should be recorded so the prescriber can see whether the medicine was appropriate. A dose given to make a shift easier is not a resident-centred indication. If the pattern suggests an unmet need, ask for a clinical and care review rather than repeating administration without question.

The resident and family may have useful information about what has helped or harmed before. Involve representatives according to the resident's preferences, capacity and lawful sharing arrangements. A family request cannot substitute for a prescription or authorise an unrecorded dose. If the resident self-administers under an agreed plan, clarify what staff need to know about last-dose timing before they provide further support.

Record why the medicine was offered and what happened after

When staff give a PRN medicine, the MAR should show the medicine, dose, date, time and administrator according to the home's system. The care record should show the reason and the resident's condition before administration. CQC's PRN guidance says the record should include the reason, amount, time for time-sensitive medicines, outcome and whether it was effective. NICE SC1 says PRN medicine should be recorded only when given, with the dose and amount left where possible.

Define when and how to evaluate the effect in the care plan. A note saying “PRN given” cannot show whether pain eased, nausea improved or the resident remained distressed. A later observation should reflect the expected effect and any adverse response. If staff cannot assess the effect within their competence, the plan should say whom to involve. A lack of effect is information for the prescriber, not merely a reason to keep giving doses until the maximum is reached.

Record when the resident asked for medicine but it was not given, and why. Perhaps the minimum interval had not passed, the prescription was unclear, the resident changed their mind or clinical advice was sought. This is not the same as signing the MAR as administered. The care record should show what support was provided instead and the next review. If the medicine was unavailable, use the supply and incident process as well. A supply gap should not be disguised as “not required.”

Keep stock and expiry control aligned with actual use. NICE says PRN medicines should stay in original packaging. CQC advises holding suitable quantities and ensuring the medicine is in date. A rarely used medicine may expire while remaining on the MAR, while a frequently used one may run out unexpectedly. Review usage and ordering so the resident has access when needed. Do not over-order simply because the medicine appears on a chart.

Review patterns, not just individual administrations

Check access across nights and weekends

A plan that works only when the usual nurse or manager is present is incomplete. Check that night and weekend staff can find the current PRN directions, see the last dose and reach the agreed clinical advice route. The resident may need the medicine outside office hours, while the supplying pharmacy may be closed. The home should know how to escalate an unclear prescription and how to manage a medicine that is unavailable without leaving a resident's symptoms unaddressed. Test the handover with a worker who was not involved in writing the plan. Ask them to explain the indication, interval, maximum amount, expected effect and review route. If they cannot, improve the record and training before relying on the process. Keep any out-of-hours advice with the resident's clinical record and share it with the next shift and usual prescriber as appropriate. A verbal answer held in one person's memory cannot support safe later doses.

A weekly or monthly review can show whether the PRN plan is working. Look at frequency, timing, reasons, dose chosen, effect and any adverse response. Does one resident ask for pain relief most nights? Does a medicine for distress appear to be given before a particular care task? Are different workers using different amounts for the same signs? Are doses recorded with no reason or effect? These are prompts for review, not automatic proof of poor care.

Bring the pattern to the prescriber and pharmacist. The underlying condition may need reassessment, the regular treatment may need change, or the PRN directions may be too vague. The resident's account should be part of the review. A high number of doses may indicate unmet need, but it may also reflect an appropriate short-term plan. The clinical team decides. The provider should ensure the agreed change reaches the prescription, label, MAR and care plan before staff act on it.

Look at a medicine that is rarely used too. Is it still appropriate? Is it in date and available? Does the resident know they can request it? Do staff recognise the indication? A zero-use record can mean the need has gone, or that the medicine is not being offered when needed. Ask the resident and care team before concluding either way. Review and stop an unnecessary medicine through the prescriber, not by silently removing it from the trolley.

For medicines used to manage behaviour, review whether the care plan identifies causes, alternatives, consent and effect. A repeated PRN dose can become an unexamined routine. A governance audit should sample the underlying care notes and resident experience, not count administrations alone. CQC's guidance and NICE recommendations make the intended effect and review integral to safe use.

Example: pain relief requested between rounds

A resident asks for their PRN pain medicine at 14:30. The worker checks the resident's current prescription, care plan and MAR. The plan identifies the pain being treated, the prescribed dose, minimum interval and what to assess after administration. The last recorded dose was at 09:00, but the worker also checks whether a visiting clinician or the resident gave a dose later. They ask the resident about the pain and whether they want the medicine. The interval and daily maximum can be verified from the authorised directions.

The trained worker gives the prescribed dose if the plan and current assessment support it. They record the reason, dose and actual time, then check the effect at the time specified in the care plan. If the pain remains severe or is different from usual, they escalate rather than repeatedly giving the medicine without review. The next shift sees the last dose time and outcome. The later medicines round does not reset the minimum interval.

If the label lacks a clear interval or the MAR conflicts with the care plan, the worker does not invent one. They contact the prescriber or pharmacist, document the advice and arrange a safe plan for the current need. The manager then fixes the conflicting documentation so the same question does not recur tomorrow. This example illustrates a decision sequence; it does not prescribe a particular medicine or interval.

Where Complys may fit

The live Complys care home guide says Complys does not replace the clinical system that holds day-to-day medicine records. Public material discusses policies, staff competence, audits and incident reviews. It does not verify PRN assessment, MAR administration, dose interval calculation, prescribing or clinical effect monitoring. Product copy should not imply those functions without verification.

Where supported, Complys could help a manager track that the medicines policy is current, staff competence has been assessed and a governance action from an audit has an owner and review date. The resident-specific PRN plan, last-dose time, administration and effect belong in the authorised care record. The provider should avoid copying detailed health information into a second administrative system without a clear purpose and access controls.

CTA: Review Complys for Care and ask which policy, training, audit and corrective-action workflows are currently available alongside the home's clinical medicines system. Related tool opportunity: A PRN plan quality checklist for the prescriber and care team, covering indication, resident choice, dose instructions, minimum interval, maximum amount, expected effect, monitoring, escalation and review. It must not calculate or authorise a dose. Suggested internal links out: Medicine refusal response, missed-dose response, care home CQC guide. Suggested links in: Care home medicines section, future medicines cluster page and any approved audit checklist. Cannibalisation boundary: This page owns the need-led decision and review process for prescribed PRN medicines in a care home. Draft 72 owns expressed refusal. Draft 70 owns a discovered missed scheduled dose. A page for every symptom or medicine would require a different clinical decision journey and specialist review, not a wording substitution.